Co-expression of osteopontin and CD44v9 in gastric cancer

International Journal of Cancer

Volumn 79, Issue 2, 1998, Pages 127-132

  Teruyoshi, U E ^a,b   Yokozaki, Hiroshi ^a   Kitadai, Yasuhiko ^a   Yamamoto, Soichiro ^a   Yasui, Wataru ^a   Ishikawa, Takenori ^b   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INCIDENCE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; STOMACH CANCER; TUMOR DIAGNOSIS;

EID: 2642676024     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V     Document Type: Article

References (22)

1. ARCH, R., WIRTH, K., HOFMANN, M., PONTA, H., MATZKU, S., HERRLICH, P. and ZÖLLER, M., Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science, 257, 682-685 (1992).
2. BEHREND, E.I., CRAIG, A.M., WILSON, S.M., DENHARDT, D.T. and CHAMBERS, A.F., Reduced malignancy of ras transformed NIH3T3 cells expressing antisense osteopontin RNA. Cancer Res., 54, 832-837 (1994).
3. BROWN, L.F., PAPADOPOULOS-SERGIOU, A., BERSE, B., MANSEAU, E.J., TOGNAZZI, K., PERRUZZI, C.A., DVORAK, H.F. and SENGER, D.R., Osteopontin expression and distribution in human carcinomas. Amer. J. Pathol., 145, 610-623 (1994).
4. CHAMBERS, A.F., CHARULATA, H. and PRINCE, C.W., Adhesion of metastatic, ras-transformed NIH3T3 cells to osteopontin, fibronectin, and laminin. Cancer Res., 53, 701-706 (1993).
5. CRAIG, A.M., BOWDEN, G.T., CHAMBERS, A.F., SPEARMAN, M.A., GREENBERG, A.H., WRIGHT, J.A., MCLEOD, M. and DENHARDT, D.T., Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine tibroblasts. Int. J. Cancer, 46, 133-137 (1990).
6. DENHARDT, D.T. and CHAMBERS, A.F., Overcoming obstacles to metastasis-defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells. J. Cell Biochem., 56, 48-51 (1994).
7. FISHER, L.W., STUBBS, III. J.T. and YOUNG, M.F., Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta. Orthop. Scand., 66, 61-65 (1995).
8. HEIDER, K.H., DÄMMRICH, J., SKROCH-ANGEL, P., MÜLLER-HERMELINK, H.K., VOLLMERS, H.P., HERRLICH, P. and PONTA, H., Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res., 53, 4197-4203 (1993).
9. HIGASHIKAWA, K., YOKOZAKI, H., UE, T., TANIYAMA, K., ISHIKAWA, T., DAVID, T. and TAHARA, E., Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues. Int. J. Cancer, 66, 11-17 (1996).
10. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER, Japanese classification of gastric carcinoma (1st English ed.), Kanehara, Tokyo (1995).
11. KITADAI, Y., BUCANA, C.D., ELLIS, L.M., ANZAI, H., TAHARA, E. and FIDLER, I.J., In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Amer. J. Pathol., 147, 1238-1247 (1995).
12. LONGCHENG, S., MUKHERJEE, A.B. and MUKHERJEE, B.B., Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene, 10, 2163-2169 (1995).
13. MAYER, B., JAUCH, K.W., GÜNTHERT, U., FIGDOR, C.G., SCHILDBERG, F.W., FUNKE, I. and JOHNSON, J.P., De-novo expression of CD44 and survival in gastric cancer. Lancet, 342, 1019-1022 (1993).
14. OLDBERG, A., FRANZÉN, A. and HEINEGARD, D., Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence. Proc. nat. Acad. Sci. (Wash.), 83, 8819-8823 (1986).
15. PATARCA, R., FREEMAN, G.J., SINGH, R.P., WEI, F.-Y., DURFEE, T., BLATTNER, F., REGNIER, D.C., KOZAK, C.A., MOCK, B.A., MORSE III, H.C., JERRELLS, T.R. and CANTOR, H., Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. J. exp. Med., 170, 145-161 (1989).
16. ROSS, F.P., CHAPPEL, J., ALVAREZ, J.I., SANDER, D., BUTLER, W.T., FRANCH-CARSON, M.C., MINTZ, K.A., ROBEY, P.G., TEITELBAUM, S.L. and CHERESH, D.A., Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha V beta 3 potentiate bone resorption. J. biol. Chem., 268, 9901-9907 (1993).
17. SAITOH, Y., KURATSU, J., TAKESHITA, H., YAMAMOTO, S., and USHIO, Y., Expression of osteopontin in human glioma. Lab Invest., 72, 55-63 (1995).
18. SENGER, D.R. and PERRUZZI, C.A., Secreted phosphoprotein markers for neoplastic transformation of human epithelial and fibroblastic cells. Cancer Res., 45, 5818-5823 (1985).
19. SINGH, R.P., PATARCA, R., SCHWARTZ, J., SINGH, P. and CANTOR, H., Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J. exp. Med., 171, 1931-1942 (1990).
20. WEBER, G.F., ASHKAR, S., GLIMCHER, M.J. and CANTOR, H., Receptor-ligand interaction between CD44 and Osteopontin (Eta-1). Science, 271, 509-512 (1996).
21. YOKOZAKI, H., ITO, R., NAKAYAMA, H., KUNIYASU, H., TANIYAMA, K. and TAHARA, E., Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett., 83, 229-234 (1994).
22. YOSHIDA, K., TSUDA, T., MATSUMURA, T., TSUJINO, T., HATTORI, T., ITO, H. and TAHARA, E., Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Arch., 57, 285-290 (1989).